aTyr Pharma | LIFE - L'Utile Ante Imposte





L'Utile Ante Imposte Cambiamento Data
Alterity Therapeutics Limited AUD -4.74M 3.53M 2024-12
Ardelyx USD -400K 467K 2025-12
aTyr Pharma USD -25.75M 6.22M 2025-09
Biogen USD 377.7M 433.7M 2026-03
Bristol-Myers Squibb USD 1.47B 1.64B 2025-12
Cipla INR 7.49B 4.2B 2026-03
Clal Biotechnology ILS 86.82M 17.9M 2022-12
Compugen USD 56.84M 63.78M 2025-12
CSL USD 2.61B 1.21B 2025-12
Curis USD 19.36M 33.34M 2025-12
GlaxoSmithKline GBP 2.14B 919M 2026-03
Grifols EUR 257.85M 190.87M 2024-12
Lakefront Biotherapeutics EUR 13.96M 769.2M 2026-03
Novartis USD 3.84B 802M 2026-03
Roche Holding CHF 4.79B 3.01B 2025-06
United Therapeutics USD 444M 6M 2025-12
Xoma USD 15.98M 24.58M 2024-06